Pictet Asset Management (UK)’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Pictet Asset Management (UK)’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-20,079	Closed	-$991K	–	850
2015 Q3	$991K	Hold	20,079	–	–	﹤0.01%	784
2015 Q2	$1.22M	Sell	20,079 -8,100	-29%	-$473K	0.01%	785
2015 Q1	$1.58M	Sell	28,179 -19,581	-41%	-$1.07M	0.01%	773
2014 Q4	$2.41M	Sell	47,760 -4,740	-9%	-$231K	0.01%	725
2014 Q3	$2.46M	Sell	52,500 -2,100	-4%	-$94.8K	0.01%	703
2014 Q2	$2.46M	Sell	54,600 -1,200	-2%	-$51.6K	0.01%	706
2014 Q1	$2.36M	Sell	55,800 -11,970	-18%	-$502K	0.01%	714
2013 Q4	$2.67M	Sell	67,770 -61,800	-48%	-$2.32M	0.01%	679
2013 Q3	$4.59M	Hold	129,570	–	–	0.03%	528
2013 Q2	$4.3M	Buy	+129,570	New	+$4.31M	0.02%	523

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pictet Asset Management (UK)'s IHE Position: Q4 2015 in Review

Pictet Asset Management (UK) sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2015, closing a stake of 20,079 shares — an estimated $991K sold.

Pictet Asset Management (UK) first reported a position in IHE in Q2 2013 and held it in 10 quarters. The position peaked at $4.59M in Q3 2013. 103 funds tracked by Wall St. Rank hold IHE as of Q4 2015.

Pictet Asset Management (UK) reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Pictet Asset Management (UK) sold 20,079 iShares US Pharmaceuticals ETF shares in Q4 2015, an estimated $991K.
Pictet Asset Management (UK) first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 10 quarters.
Pictet Asset Management (UK)'s iShares US Pharmaceuticals ETF position peaked at $4.59M in Q3 2013.
103 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2015, filed 12 Feb 2016.